Literature DB >> 16571380

Histamine increases sphingosine kinase-1 expression and activity in the human arterial endothelial cell line EA.hy 926 by a PKC-alpha-dependent mechanism.

Andrea Huwiler1, Frauke Döll, Shuyu Ren, Sabine Klawitter, Anna Greening, Isolde Römer, Svetlana Bubnova, Luise Reinsberg, Josef Pfeilschifter.   

Abstract

Sphingosine 1-phosphate (S1P) is a potent mitogenic signal generated from sphingosine by the action of sphingosine kinases (SKs). In this study, we show that in the human arterial endothelial cell line EA.hy 926 histamine induces a time-dependent upregulation of the SK-1 mRNA and protein expression which is followed by increased SK-1 activity. A similar upregulation of SK-1 is also observed with the direct protein kinase C activator 12-O-tetradecanoylphorbol-13-acetate (TPA). In contrast, SK-2 activity is not affected by neither histamine nor TPA. The increased SK-1 protein expression is due to stimulated de novo synthesis since cycloheximide inhibited the delayed SK-1 protein upregulation. Moreover, the increased SK-1 mRNA expression results from an increased promoter activation by histamine and TPA. In mechanistic terms, the transcriptional upregulation of SK-1 is dependent on PKC and the extracellular signal-regulated protein kinase (ERK) cascade since staurosporine and the MEK inhibitor U0126 abolish the TPA-induced SK-1 induction. Furthermore, the histamine effect is abolished by the H1-receptor antagonist diphenhydramine, but not by the H2-receptor antagonist cimetidine. Parallel to the induction of SK-1, histamine and TPA stimulate an increased migration of endothelial cells, which is prevented by depletion of the SK-1 by small interfering RNA (siRNA). To appoint this specific cell response to a specific PKC isoenzyme, siRNA of PKC-alpha, -delta, and -epsilon were used to selectively downregulate the respective isoforms. Interestingly, only depletion of PKC-alpha leads to a complete loss of TPA- and histamine-triggered SK-1 induction and cell migration. In summary, these data show that PKC-alpha activation in endothelial cells by histamine-activated H1-receptors, or by direct PKC activators leads to a sustained upregulation of the SK-1 protein expression and activity which, in turn, is critically involved in the mechanism of endothelial cell migration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16571380     DOI: 10.1016/j.bbalip.2006.02.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  22 in total

1.  The sphingosine kinase 1 inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophenyl)thiazole induces proteasomal degradation of sphingosine kinase 1 in mammalian cells.

Authors:  Carolyn Loveridge; Francesca Tonelli; Tamara Leclercq; Keng Gat Lim; Jaclyn S Long; Evgeny Berdyshev; Rothwelle J Tate; Viswanathan Natarajan; Stuart M Pitson; Nigel J Pyne; Susan Pyne
Journal:  J Biol Chem       Date:  2010-10-06       Impact factor: 5.157

2.  Sphingosine kinase 1 is critically involved in nitric oxide-mediated human endothelial cell migration and tube formation.

Authors:  Stephanie Schwalm; Josef Pfeilschifter; Andrea Huwiler
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

Review 3.  Regulation and functional roles of sphingosine kinases.

Authors:  Regina Alemany; Chris J van Koppen; Kerstin Danneberg; Michael Ter Braak; Dagmar Meyer Zu Heringdorf
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-01-23       Impact factor: 3.000

4.  Renal mesangial cells: moving on sphingosine kinase-1.

Authors:  D Meyer zu Heringdorf; K H Jakobs
Journal:  Br J Pharmacol       Date:  2007-01-02       Impact factor: 8.739

5.  Extracellular nucleotides induce migration of renal mesangial cells by upregulating sphingosine kinase-1 expression and activity.

Authors:  S Klawitter; L P Hofmann; J Pfeilschifter; A Huwiler
Journal:  Br J Pharmacol       Date:  2007-01-02       Impact factor: 8.739

6.  Phospholipase C and protein kinase C-β 2 mediate insulin-like growth factor II-dependent sphingosine kinase 1 activation.

Authors:  Hesham M El-Shewy; Souzan A Abdel-Samie; Abdelmohsen M Al Qalam; Mi-Hye Lee; Kazuyuki Kitatani; Viviana Anelli; Ayad A Jaffa; Lina M Obeid; Louis M Luttrell
Journal:  Mol Endocrinol       Date:  2011-10-20

7.  Interleukin-1 regulates the expression of sphingosine kinase 1 in glioblastoma cells.

Authors:  Barbara S Paugh; Lauren Bryan; Steven W Paugh; Katarzyna M Wilczynska; Silvina M Alvarez; Sandeep K Singh; Dmitri Kapitonov; Hanna Rokita; Sarah Wright; Irene Griswold-Prenner; Sheldon Milstien; Sarah Spiegel; Tomasz Kordula
Journal:  J Biol Chem       Date:  2008-12-11       Impact factor: 5.157

8.  FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cells.

Authors:  Francesca Tonelli; Keng Gat Lim; Carolyn Loveridge; Jaclyn Long; Stuart M Pitson; Gabor Tigyi; Robert Bittman; Susan Pyne; Nigel J Pyne
Journal:  Cell Signal       Date:  2010-06-04       Impact factor: 4.315

Review 9.  Targeting SphK1 as a new strategy against cancer.

Authors:  Dai Shida; Kazuaki Takabe; Dmitri Kapitonov; Sheldon Milstien; Sarah Spiegel
Journal:  Curr Drug Targets       Date:  2008-08       Impact factor: 3.465

Review 10.  Regulation and functions of sphingosine kinases in the brain.

Authors:  Lauren Bryan; Tomasz Kordula; Sarah Spiegel; Sheldon Milstien
Journal:  Biochim Biophys Acta       Date:  2008-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.